Biggest News Aggregation in the World
📰 Development Corp News

Page 83 - Development Corp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Development Corp. Real-time updates on events, politics, business and more.

Osisko Development (OTCMKTS:RNGTF) Stock Price Up 3.1%

Osisko Development Corp. (OTCMKTS:RNGTF – Get Rating) rose 3.1% during trading on Monday . The company traded as high as $3.26 and last traded at $3.26. Approximately 3,300 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 43,235 shares. The stock had previously closed at $3.16. Osisko Development […]
United Kingdom Osisko Development Osisko Development Corp Osisko Development Stock Get Rating Development Corp

Men who matter 2022: Because they matter as people

Men who matter will take center stage in PeopleAsia’s “Men Who Matter” awards night unfolding this week at the New World Makati Hotel, with society’s movers and shakers applauding these accomplished men. The awards celebrate not just the masculine gender — but the attributes that make them matter as people.
Philip Barnes Jack Teotico Imelda Ilanan Enrique Posas Ed Lingao Carl Tamayo

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Glenmark Pharmaceuticals Ltd.: Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development
Hong Kong British Columbia Republic Of East Timor Sri Lanka Monika Tandon

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ --Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - peer reviewed, high impact journal published the successful phase 3 clinical trial results of SaNOtize's Nitric Oxide Nasal Spray (NONS) study titled: 'SARS-CoV-2 accelerated clearance using a novel nitric oxide na...
Hong Kong British Columbia East Timor Republic Of Sri Lanka Monika Tandon

Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trials on NONS Spray for COVID-19 in Lancet Journal

Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - peer reviewed, high impact journal published the successful phase 3 clinical trial results of SaNOtizes Nitric Oxide Nasal Spray (NONS) study titled: SARS-CoV-2 accelerated clearance using a novel nitric oxide n...
Hong Kong British Columbia Republic Of East Timor Sri Lanka Monika Tandon

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science